{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:41:34Z","timestamp":1793835694328,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05328-6","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:46:42Z","timestamp":1782964002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Insights into antimicrobial resistance: dissemination and molecular epidemiology of carbapenemase and AmpC genes in uropathogenic Escherichia coli"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam","family":"Shirzadian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Foroohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Fallah Vosoughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervindokht","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Golpasand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"5328_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/antibiotics14050485","volume":"14","author":"H Ziadi","year":"2025","unstructured":"Ziadi H, Chougrani F, Cheriguene A, Carballeira L, Garc\u00eda V, Mora A. Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and High-Risk Escherichia coli CC131, with the First Report of ST1193 as a Causative Agent of Urinary Tract Infections in Human Patients in Algeria. Antibiotics. 2025;14:485.","journal-title":"Antibiotics"},{"key":"5328_CR2","first-page":"445","volume":"28","author":"P Behzadi","year":"2008","unstructured":"Behzadi P, Behzadi E. The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, Iran. Turk Klin Tip Bilim. 2008;28:445\u20139.","journal-title":"Turk Klin Tip Bilim"},{"key":"5328_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-025-04643-5","volume":"399","author":"S Ahmadi","year":"2026","unstructured":"Ahmadi S, Foroohi F, Shirzadian M, Vosoughi AF, Golpasand T, Behzadi P. Distribution of acquired carbapenemase genes among uropathogenic Escherichia coli. Naunyn Schmiedebergs Arch Pharmacol. 2026;399:1\u201318.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5328_CR4","doi-asserted-by":"publisher","first-page":"888205","DOI":"10.3389\/fpubh.2022.888205","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front public health. 2022;10:888205.","journal-title":"Front public health"},{"key":"5328_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"5328_CR6","first-page":"24555","volume":"4","author":"A Brolund","year":"2014","unstructured":"Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective. Infect Ecol Epidemiol. 2014;4:24555.","journal-title":"Infect Ecol Epidemiol"},{"key":"5328_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13756-020-00856-w","volume":"9","author":"ES Mohamed","year":"2020","unstructured":"Mohamed ES, Khairy RM, Abdelrahim SS. Prevalence and molecular characteristics of ESBL and AmpC \u03b2-lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrob Resist Infect Control. 2020;9:198.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5328_CR8","doi-asserted-by":"publisher","first-page":"1183236","DOI":"10.3389\/fmicb.2023.1183236","volume":"14","author":"P Behzadi","year":"2023","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Autr\u00e1n G\u00f3mez AM, Pinheiro M, Sarshar M. Uropathogens, urinary tract infections, the host-pathogen interactions and treatment. Front Microbiol. 2023;14:1183236.","journal-title":"Front Microbiol"},{"key":"5328_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/5584_2020_566","volume":"15","author":"P Behzadi","year":"2020","unstructured":"Behzadi P, Urb\u00e1n E, Matuz M, Benk\u0151 R, Gajd\u00e1cs M. The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Adv Microbiol Infect Dis Public Health: Volume. 2020;15:35\u201369.","journal-title":"Adv Microbiol Infect Dis Public Health: Volume"},{"key":"5328_CR10","doi-asserted-by":"crossref","unstructured":"Behzadi P, Behzadi E. Uropathogenic Escherichia coli: An ideal resource for DNA microarray probe designing. In Proceedings of the International Conference on Bioinformatics and Biomedical Engineering, 2017; pp. 12\u201319.","DOI":"10.1007\/978-3-319-56154-7_2"},{"key":"5328_CR11","doi-asserted-by":"crossref","unstructured":"Behzadi P, Dodero VI, Golubnitschaja O. Systemic inflammation as the health-related communication tool between the human host and gut microbiota in the framework of predictive, preventive, and personalized medicine. In All around suboptimal health: advanced approaches by predictive, preventive and personalised medicine for healthy populations; Springer: 2024; pp. 203\u2013241.","DOI":"10.1007\/978-3-031-46891-9_15"},{"key":"5328_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/pathogens11091015","volume":"11","author":"P Behzadi","year":"2022","unstructured":"Behzadi P, Gajd\u00e1cs M, Pall\u00f3s P, \u00d3nodi B, St\u00e1jer A, Matusovits D, K\u00e1rp\u00e1ti K, Buri\u00e1n K, Battah B, Ferrari M. Relationship between biofilm-formation, phenotypic virulence factors and antibiotic resistance in environmental Pseudomonas aeruginosa. Pathogens. 2022;11:1015.","journal-title":"Pathogens"},{"key":"5328_CR13","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1007\/s11033-020-05651-9","volume":"47","author":"P Behzadi","year":"2020","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Karpi\u0144ski TM, Issakhanian L. Metallo-\u00df-lactamases: a review. Mol Biol Rep. 2020;47:6281\u201394.","journal-title":"Mol Biol Rep"},{"key":"5328_CR14","doi-asserted-by":"publisher","first-page":"1294869","DOI":"10.3389\/fimmu.2023.1294869","volume":"14","author":"P Behzadi","year":"2023","unstructured":"Behzadi P, Kim C-H, Pawlak EA, Algammal A. The innate and adaptive immune system in human urinary system. Front Immunol. 2023;14:1294869.","journal-title":"Front Immunol"},{"key":"5328_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.eururo.2015.09.025","volume":"69","author":"P Behzadi","year":"2016","unstructured":"Behzadi P, Najafi A, Behzadi E, Ranjbar R. Microarray long oligo probe designing for Escherichia coli: an in-silico DNA marker extraction. Cent Eur J Urol. 2016;69:105.","journal-title":"Cent Eur J Urol"},{"key":"5328_CR16","first-page":"452","volume":"68","author":"N Jahandeh","year":"2015","unstructured":"Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. Cent Eur J Urol. 2015;68:452.","journal-title":"Cent Eur J Urol"},{"key":"5328_CR17","doi-asserted-by":"crossref","unstructured":"Chong KJ, Feng H, Letchumanan V, Arip M, Fatokun O, Mochamad L, Ng CT, Chinnapan S, Selvaraja M. Tackling Microbial Resistance and Emerging Pathogens with Next-Generation Antibiotics. Progress In Microbes & Molecular Biology 2024, 7.","DOI":"10.36877\/pmmb.a0000447"},{"key":"5328_CR18","doi-asserted-by":"publisher","unstructured":"Kalyanasundaram KD, Rengasamy KR. The role of beta-lactamase inhibitors in combating antibiotic resistance: a historical and contemporary analysis. Microb Pathog. 2026;210:108194. https:\/\/doi.org\/10.1016\/j.micpath.2025.108194","DOI":"10.1016\/j.micpath.2025.108194"},{"key":"5328_CR19","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2174\/1381612825999190619130216","volume":"25","author":"L Issakhanian","year":"2019","unstructured":"Issakhanian L, Behzadi P. Antimicrobial agents and urinary tract infections. Curr Pharm Design. 2019;25:1409\u201323.","journal-title":"Curr Pharm Design"},{"key":"5328_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.idc.2020.05.001","volume":"34","author":"KM Papp-Wallace","year":"2020","unstructured":"Papp-Wallace KM, Mack AR, Taracila MA, Bonomo RA. Resistance to novel \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations: the price of progress. Infect Dis Clin N Am. 2020;34:773.","journal-title":"Infect Dis Clin N Am"},{"key":"5328_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-021-02179-1","volume":"21","author":"C Ejikeugwu","year":"2021","unstructured":"Ejikeugwu C, Nworie O, Saki M, Al-Dahmoshi HO, Al-Khafaji NS, Ezeador C, Nwakaeze E, Eze P, Oni E, Obi C. Metallo-\u03b2-lactamase and AmpC genes in Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolates from abattoir and poultry origin in Nigeria. BMC Microbiol. 2021;21:1\u20139.","journal-title":"BMC Microbiol"},{"key":"5328_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmacy12050142","volume":"12","author":"G Tebano","year":"2024","unstructured":"Tebano G, Zaghi I, Cricca M, Cristini F. Antibiotic treatment of infections caused by AmpC-producing Enterobacterales. Pharmacy. 2024;12:142.","journal-title":"Pharmacy"},{"key":"5328_CR23","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.tcsw.2025.100154","volume":"14","author":"D Pandey","year":"2025","unstructured":"Pandey D, Gupta GI. AmpC \u03b2-lactamases: A key to antibiotic resistance in ESKAPE pathogens. Cell Surf. 2025;14:100154. https:\/\/doi.org\/10.1016\/j.tcsw.2025.100154.","journal-title":"Cell Surf"},{"key":"5328_CR24","doi-asserted-by":"publisher","first-page":"e00150","DOI":"10.1128\/cmr.00150-21","volume":"35","author":"A Philippon","year":"2022","unstructured":"Philippon A, Arlet G, Labia R, Iorga BI. Class C \u03b2-lactamases: molecular characteristics. Clin Microbiol Rev. 2022;35:e00150\u201300121.","journal-title":"Clin Microbiol Rev"},{"key":"5328_CR25","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. 2024:ciae403. https:\/\/doi.org\/10.1093\/cid\/ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"5328_CR26","doi-asserted-by":"publisher","first-page":"105860","DOI":"10.1016\/j.ijantimicag.2019.105860","volume":"55","author":"SH Tan","year":"2020","unstructured":"Tan SH, Ng TM, Chew KL, Yong J, Wu JE, Yap MY, Heng ST, Ng WHW, Wan S, Cheok SJH. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems. Int J Antimicrob Agents. 2020;55:105860.","journal-title":"Int J Antimicrob Agents"},{"key":"5328_CR27","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/ciz173","volume":"69","author":"PD Tamma","year":"2019","unstructured":"Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ, RA AR. .L.G.T.P.D.Y.B. A primer on AmpC \u03b2-lactamases: necessary knowledge for an increasingly multidrug-resistant world. Clin Infect Dis. 2019;69:1446\u201355.","journal-title":"Clin Infect Dis"},{"key":"5328_CR28","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Guti\u00e9rrez-Guti\u00e9rrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018;31. https:\/\/doi.org\/10.1128\/cmr. 00079\u2009\u2013\u200900017.","DOI":"10.1128\/cmr"},{"key":"5328_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023;12:234.","journal-title":"Antibiotics"},{"key":"5328_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/antibiotics13030257","volume":"13","author":"T Karampatakis","year":"2024","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Pan-genome plasticity and virulence factors: a natural treasure trove for Acinetobacter baumannii. Antibiotics. 2024;13:257.","journal-title":"Antibiotics"},{"key":"5328_CR31","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/microorganisms13091983","volume":"13","author":"T Karampatakis","year":"2025","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-Resistant acinetobacter baumannii: virulence factors, molecular epidemiology, and latest updates in treatment options. Microorganisms. 2025;13:1983.","journal-title":"Microorganisms"},{"key":"5328_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/antibiotics14040353","volume":"14","author":"T Karampatakis","year":"2025","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Pseudomonas aeruginosa\u2019s resistome: pan-genomic plasticity, the impact of transposable elements and jumping genes. Antibiotics. 2025;14:353.","journal-title":"Antibiotics"},{"key":"5328_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/antibiotics15040359","volume":"15","author":"T Karampatakis","year":"2026","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-Resistant Serratia marcescens: Genomic Plasticity, Virulence Architecture, and the Expanding Threat of Multidrug Resistance. Antibiotics. 2026;15:359.","journal-title":"Antibiotics"},{"key":"5328_CR34","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/molecules29163944","volume":"29","author":"JL Ortega-Balleza","year":"2024","unstructured":"Ortega-Balleza JL, V\u00e1zquez-Jim\u00e9nez LK, Ortiz-P\u00e9rez E, Avalos-Navarro G, Paz-Gonz\u00e1lez AD, Lara-Ram\u00edrez EE, Rivera G. Current Strategy for Targeting Metallo-\u03b2-Lactamase with Metal-Ion-Binding Inhibitors. Molecules. 2024;29:3944.","journal-title":"Molecules"},{"key":"5328_CR35","doi-asserted-by":"publisher","first-page":"001462","DOI":"10.1099\/jmm.0.001462","volume":"70","author":"T Armstrong","year":"2021","unstructured":"Armstrong T, Fenn SJ, Hardie KR. JMM Profile: Carbapenems: a broad-spectrum antibiotic. J Med Microbiol. 2021;70:001462.","journal-title":"J Med Microbiol"},{"key":"5328_CR36","doi-asserted-by":"publisher","unstructured":"Ali S, Burke LP, Fitzpatrick F, Fitzgerald-Hughes D. A Scoping Review of Disinfection Strategies for Carbapenemase-Producing Enterobacterales (CPE) in Hospital Water Systems. J Hosp Infect. 2026;168:1-12. https:\/\/doi.org\/10.1016\/j.jhin.2025.10.021.","DOI":"10.1016\/j.jhin.2025.10.021"},{"key":"5328_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/antibiotics14020141","volume":"14","author":"G Alvisi","year":"2025","unstructured":"Alvisi G, Curtoni A, Fonnesu R, Piazza A, Signoretto C, Piccinini G, Sassera D, Gaibani P. Epidemiology and genetic traits of carbapenemase-producing enterobacterales: A global threat to human health. Antibiotics. 2025;14:141.","journal-title":"Antibiotics"},{"key":"5328_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/antibiotics13040295","volume":"13","author":"E-C Chelaru","year":"2024","unstructured":"Chelaru E-C, Muntean A-A, Hogea M-O, Muntean M-M, Popa M-I, Popa G-L. The importance of carbapenemase-producing Enterobacterales in African countries: Evolution and current burden. Antibiotics. 2024;13:295.","journal-title":"Antibiotics"},{"key":"5328_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/antibiotics14010042","volume":"14","author":"A Tristancho-Bar\u00f3","year":"2025","unstructured":"Tristancho-Bar\u00f3 A, Franco-Fobe LE, Ariza MP, Milagro A, L\u00f3pez-Calleja AI, Fortu\u00f1o B, L\u00f3pez C, Latorre-Mill\u00e1n M, Clusa L, Mart\u00ednez R. Genomic Characterization of Carbapenemase-Producing Enterobacteriaceae from Clinical and Epidemiological Human Samples. Antibiotics. 2025;14:42.","journal-title":"Antibiotics"},{"key":"5328_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12879-024-09307-y","volume":"24","author":"D Jenkins","year":"2024","unstructured":"Jenkins D, Auckland C, Chadwick C, Dodgson A, Enoch D, Goldenberg S, Hussain A, Martin J, Spooner E, Whalley T. A practical approach to screening for carbapenemase-producing Enterobacterales\u2013views of a group of multidisciplinary experts from English hospitals. BMC Infect Dis. 2024;24:444.","journal-title":"BMC Infect Dis"},{"key":"5328_CR41","doi-asserted-by":"publisher","first-page":"1135614","DOI":"10.3389\/fmicb.2023.1135614","volume":"14","author":"A Algammal","year":"2023","unstructured":"Algammal A, Hetta HF, Mabrok M, Behzadi P. Emerging multidrug-resistant bacterial pathogens superbugs: A rising public health threat. Front Microbiol. 2023;14:1135614.","journal-title":"Front Microbiol"},{"key":"5328_CR42","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.24976\/Discov.Med.202436188.177","volume":"36","author":"AM Algammal","year":"2024","unstructured":"Algammal AM, Behzadi P. Antimicrobial resistance: a global public health concern that needs perspective combating strategies and new talented antibiotics. Discov Med. 2024;36:1911\u20133.","journal-title":"Discov Med"},{"key":"5328_CR43","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1186\/s12879-025-11632-9","volume":"25","author":"AN Kebriaee","year":"2025","unstructured":"Kebriaee AN, Behzadi P, Mohammadian T, Imani Fooladi AA, Hosseini MS. Distribution of antimicrobial resistance genes and virulence genes in different genotypes of Acinetobacter baumannii. BMC Infect Dis. 2025;25:1230.","journal-title":"BMC Infect Dis"},{"key":"5328_CR44","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/14756366.2017.1344235","volume":"32","author":"T Naas","year":"2017","unstructured":"Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI. Beta-lactamase database (BLDB)\u2013structure and function. J Enzyme Inhib Med Chem. 2017;32:917\u20139.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5328_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","volume":"46","author":"A Philippon","year":"2002","unstructured":"Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type \u03b2-lactamases. Antimicrob Agents Chemother. 2002;46:1\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"5328_CR46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12866-024-03472-5","volume":"24","author":"T Golpasand","year":"2024","unstructured":"Golpasand T, Keshvari M, Behzadi P. Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli. BMC Microbiol. 2024;24:344.","journal-title":"BMC Microbiol"},{"key":"5328_CR47","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1128\/AAC.43.8.1924","volume":"43","author":"A Bauernfeind","year":"1999","unstructured":"Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U. A novel type of AmpC \u03b2-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother. 1999;43:1924\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"5328_CR48","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1128\/AAC.44.6.1470-1478.2000","volume":"44","author":"D Girlich","year":"2000","unstructured":"Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P. Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob Agents Chemother. 2000;44:1470\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"5328_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA. AmpC \u03b2-lactamases. Clin Microbiol Rev. 2009;22:161\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"5328_CR50","doi-asserted-by":"publisher","first-page":"614058","DOI":"10.3389\/fmicb.2021.614058","volume":"12","author":"E-J Yoon","year":"2021","unstructured":"Yoon E-J, Jeong SH. Mobile carbapenemase genes in Pseudomonas aeruginosa. Front Microbiol. 2021;12:614058.","journal-title":"Front Microbiol"},{"key":"5328_CR51","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.mgene.2021.100881","volume":"28","author":"MS Khonsari","year":"2021","unstructured":"Khonsari MS, Behzadi P, Foroohi F. The prevalence of type 3 fimbriae in Uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene. 2021;28:100881.","journal-title":"Meta Gene"},{"key":"5328_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13353-020-00542-y","volume":"61","author":"A Hozzari","year":"2020","unstructured":"Hozzari A, Behzadi P, Kerishchi Khiabani P, Sholeh M, Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J Appl Genet. 2020;61:265\u201373.","journal-title":"J Appl Genet"},{"key":"5328_CR53","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1874285801711010330","volume":"11","author":"R Ranjbar","year":"2017","unstructured":"Ranjbar R, Behzadi P, Najafi A, Roudi R. DNA microarray for rapid detection and identification of food and water borne bacteria: from dry to wet lab. open Microbiol J. 2017;11:330.","journal-title":"open Microbiol J"},{"key":"5328_CR54","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2023","unstructured":"CLSI. In: Supplement CLSI M100, editor. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. USA: Clinical and Laboratory Standards Institute; 2023.","edition":"33"},{"key":"5328_CR55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske C, Harbarth S, Hindler J, Kahlmeter G, Olsson-Liljequist B. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"5328_CR56","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/antibiotics10050476","volume":"10","author":"V Silago","year":"2021","unstructured":"Silago V, Kovacs D, Samson H, Seni J, Matthews L, Oravcov\u00e1 K, Lupindu AM, Hoza AS, Mshana SE. Existence of multiple ESBL genes among phenotypically confirmed ESBL producing Klebsiella pneumoniae and Escherichia coli concurrently isolated from clinical, colonization and contamination samples from neonatal units at Bugando Medical Center, Mwanza, Tanzania. Antibiotics. 2021;10:476.","journal-title":"Antibiotics"},{"key":"5328_CR57","doi-asserted-by":"publisher","first-page":"e0001344","DOI":"10.1371\/journal.pgph.0001344","volume":"3","author":"J Muleme","year":"2023","unstructured":"Muleme J, Musoke D, Balugaba BE, Kisaka S, Makumbi FE, Buregyeya E, Isunju JB, Wambi R, Mugambe RK, Kankya C. Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda. PLoS Global Public Health. 2023;3:e0001344.","journal-title":"PLoS Global Public Health"},{"key":"5328_CR58","doi-asserted-by":"publisher","first-page":"36310","DOI":"10.1038\/s41598-025-14114-9","volume":"15","author":"N Sipahi","year":"2025","unstructured":"Sipahi N, Cevik YN. Differences and fingerprints of ESBL-producing E. coli from chicken faeces. Sci Rep. 2025;15:36310.","journal-title":"Sci Rep"},{"key":"5328_CR59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jgar.2020.03.011","volume":"22","author":"KS Rizi","year":"2020","unstructured":"Rizi KS, Mosavat A, Youssefi M, Jamehdar SA, Ghazvini K, Safdari H, Amini Y, Farsiani H. High prevalence of blaCMY AmpC beta-lactamase in ESBL co-producing Escherichia coli and Klebsiella spp. clinical isolates in the northeast of Iran. J global Antimicrob Resist. 2020;22:477\u201382.","journal-title":"J global Antimicrob Resist"},{"key":"5328_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s15010-019-01291-9","volume":"47","author":"S Meini","year":"2019","unstructured":"Meini S, Tascini C, Cei M, Sozio E, Rossolini GM. AmpC \u03b2-lactamase-producing Enterobacterales: what a clinician should know. Infection. 2019;47:363\u201375.","journal-title":"Infection"},{"key":"5328_CR61","doi-asserted-by":"publisher","first-page":"e17449","DOI":"10.5812\/jjm.17449","volume":"8","author":"P Behzadi","year":"2014","unstructured":"Behzadi P, Ranjbar R, Alavian SM. Nucleic acid-based approaches for detection of viral hepatitis. Jundishapur J Microbiol. 2014;8:e17449.","journal-title":"Jundishapur J Microbiol"},{"key":"5328_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/mdr.2020.0432","volume":"28","author":"CW Muriuki","year":"2022","unstructured":"Muriuki CW, Ogonda LA, Kyanya C, Matano D, Masakhwe C, Odoyo E, Musila L. Phenotypic and genotypic characteristics of uropathogenic Escherichia coli isolates from Kenya. Microb drug Resist. 2022;28:31\u20138.","journal-title":"Microb drug Resist"},{"key":"5328_CR63","doi-asserted-by":"publisher","unstructured":"Thapa Shrestha U, Shrestha S, Adhikari N, Rijal KR, Shrestha B, Adhikari B, Banjara MR, Ghimire P. Plasmid profiling and occurrence of \u03b2-lactamase enzymes in multidrug-resistant uropathogenic Escherichia coli in Kathmandu, Nepal. Infect drug Resist. 2020;13:1905\u201317. https:\/\/doi.org\/10.2147\/IDR.S250591.","DOI":"10.2147\/IDR.S250591"},{"key":"5328_CR64","doi-asserted-by":"publisher","first-page":"100947","DOI":"10.1016\/j.nmni.2021.100947","volume":"45","author":"M Sadeghi","year":"2022","unstructured":"Sadeghi M, Ebrahim-Saraie HS, Mojtahedi A. Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran. New microbes new infections. 2022;45:100947.","journal-title":"New microbes new infections"},{"key":"5328_CR65","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1007\/s11033-021-06814-y","volume":"48","author":"A Bahramian","year":"2021","unstructured":"Bahramian A, Khoshnood S, Hashemi N, Moradi M, Karimi-Yazdi M, Jalallou N, Saki M. Identification of metallo-\u03b2-lactamases and AmpC production among Escherichia coli strains isolated from hemodialysis patients with urinary tract infection. Mol Biol Rep. 2021;48:7883\u201392.","journal-title":"Mol Biol Rep"},{"key":"5328_CR66","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.phrp.2015.02.001","volume":"6","author":"A Maleki","year":"2015","unstructured":"Maleki A, Khosravi A, Ghafourian S, Pakzad I, Hosseini S, Ramazanzadeh R, Sadeghifard N. High prevalence of AmpC \u03b2-Lactamases in clinical isolates of Escherichia coli in Ilam, Iran. Osong public health Res Perspect. 2015;6:201\u20134.","journal-title":"Osong public health Res Perspect"},{"key":"5328_CR67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/20477724.2021.2011578","volume":"116","author":"A Qasemi","year":"2022","unstructured":"Qasemi A, Rahimi F, Katouli M. Clonal groups of extended-spectrum \u03b2-lactamase and biofilm producing uropathogenic Escherichia coli in Iran. Pathogens Global Health. 2022;116:485\u201397.","journal-title":"Pathogens Global Health"},{"key":"5328_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.micpath.2016.10.010","volume":"100","author":"SK Singh","year":"2016","unstructured":"Singh SK, Seema K, Gupta M. Detection of AmpC \u03b2-lactamase and adherence factors in uropathogenic Escherichia coli isolated from aged patients. Microb Pathog. 2016;100:293\u20138.","journal-title":"Microb Pathog"},{"key":"5328_CR69","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jgar.2018.03.006","volume":"14","author":"S Shahbazi","year":"2018","unstructured":"Shahbazi S, Karam MRA, Habibi M, Talebi A, Bouzari S. Distribution of extended-spectrum \u03b2-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J global Antimicrob Resist. 2018;14:118\u201325.","journal-title":"J global Antimicrob Resist"},{"key":"5328_CR70","first-page":"98","volume":"10","author":"AR Ganjo","year":"2022","unstructured":"Ganjo AR. Extended-spectrum \u03b2-lactamases and AMPC production among uropathogenic isolates of Escherichia coli and antibiogram pattern. Aro-The Sci J Koya Univ. 2022;10:98\u2013103.","journal-title":"Aro-The Sci J Koya Univ"},{"key":"5328_CR71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1128\/JCM.01542-07","volume":"46","author":"A Carattoli","year":"2008","unstructured":"Carattoli A, Garc\u00eda-Fern\u00e1ndez A, Varesi P, Fortini D, Gerardi S, Penni A, Mancini C, Giordano A. Molecular epidemiology of Escherichia coli producing extended-spectrum \u03b2-lactamases isolated in Rome, Italy. J Clin Microbiol. 2008;46:103\u20138.","journal-title":"J Clin Microbiol"},{"key":"5328_CR72","first-page":"2173","volume":"7","author":"M Sharma","year":"2013","unstructured":"Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of Extended Spectrum \u03b2-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn research: JCDR. 2013;7:2173.","journal-title":"J Clin Diagn research: JCDR"},{"key":"5328_CR73","doi-asserted-by":"publisher","unstructured":"Gantasala E, Bhat S, Saralaya V, Jayaram M, Udayalaxmi J. Genotypic and phenotypic expression of antibiotic resistance patterns of uropathogenic Enterobacteriaceae. Infect Drug Resist. 2022;15:3991\u20139. https:\/\/doi.org\/10.2147\/IDR.S362445.","DOI":"10.2147\/IDR.S362445"},{"key":"5328_CR74","doi-asserted-by":"publisher","first-page":"e0262984","DOI":"10.1371\/journal.pone.0262984","volume":"17","author":"SM Gatya Al-Mayahie","year":"2022","unstructured":"Gatya Al-Mayahie SM, Al-Guranie DRdT, Hussein AA, Bachai ZA. Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province\/Iraq. PLoS ONE. 2022;17:e0262984.","journal-title":"PLoS ONE"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05328-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:38Z","timestamp":1790078618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05328-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05328-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is derived from the MSc thesis of Maryam Shirzadian, approved by the Islamic Azad University, Shahr-e-Qods Branch. Ethical approval for the study was obtained from the Ethics Committee of the Islamic Azad University, Shahr-e-Qods Branch, under the approval number IR.IAU.QODS.REC.1402.003 As all patient data were anonymized, informed consent was not required. Only the age and gender of patients with UTIs were accessible, while clinical signs and symptoms were unavailable. The study was conducted in accordance with the principles outlined in the Declaration of Helsinki, and the requirement for informed consent was formally waived by the Ethics Committee of the Islamic Azad University, Shahr-e-Qods Branch.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. P.B. is the editorial board member of BMC Infectious Diseases, BMC Microbiology, BMC Research Notes and Archives of Microbiology.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"826"}}